Morgan Stanley’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $19.8K | Sell |
|
|||||
|
2023
Q4 | $27.1K | Sell |
|
|||||
|
2023
Q3 | $32.4K | Sell |
|
|||||
|
2023
Q2 | $277K | Buy |
|
|||||
|
2023
Q1 | $254K | Buy |
|
|||||
|
2022
Q4 | $137K | Sell |
|
|||||
|
2022
Q3 | $518K | Sell |
|
|||||
|
2022
Q2 | $693K | Buy |
|
|||||
|
2022
Q1 | $434K | Buy |
|
|||||
|
2021
Q4 | $631K | Sell |
|
|||||
|
2021
Q3 | $9.27M | Buy |
|
|||||
|
2021
Q2 | $2.03M | Buy |
|